Role of Biomarkers in the Clinical Management of Glioblastomas: What are the Barriers and How Can We Overcome Them?
about
Screening for EGFR amplifications with a novel method and their significance for the outcome of glioblastoma patients.Clinical neuropathology practice guide 3-2013: levels of evidence and clinical utility of prognostic and predictive candidate brain tumor biomarkersPersonalized treatment strategies in glioblastoma: MGMT promoter methylation status.Statistical and practical considerations for clinical evaluation of predictive biomarkers.Prognostic and predictive biomarkers in adult and pediatric gliomas: toward personalized treatment.Overexpression and Nucleolar Localization of γ-Tubulin Small Complex Proteins GCP2 and GCP3 in Glioblastoma.
P2860
Role of Biomarkers in the Clinical Management of Glioblastomas: What are the Barriers and How Can We Overcome Them?
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Role of Biomarkers in the Clin ...... and How Can We Overcome Them?
@ast
Role of Biomarkers in the Clin ...... and How Can We Overcome Them?
@en
type
label
Role of Biomarkers in the Clin ...... and How Can We Overcome Them?
@ast
Role of Biomarkers in the Clin ...... and How Can We Overcome Them?
@en
prefLabel
Role of Biomarkers in the Clin ...... and How Can We Overcome Them?
@ast
Role of Biomarkers in the Clin ...... and How Can We Overcome Them?
@en
P2093
P2860
P356
P1476
Role of Biomarkers in the Clin ...... and How Can We Overcome Them?
@en
P2093
Kerrie L McDonald
Paul Kleihues
P2860
P356
10.3389/FNEUR.2012.00188
P577
2012-01-01T00:00:00Z